ARCHIVES

Regorafenib Trial Meets Primary Endpoint; Overall Survival Improved by 29 Percent

This article is from The Cancer Letter archive.

Vol. 35 No. 1 | January 27, 2012

Download PDF Visit The Full Archive

Related Articles

UPCI Recruits Shin To Lead Head & Neck Cancer Program.

April 27, 2001

Patient Advocacy: Breast Cancer Coalition To Hold International Meeting In Brussels

January 17, 1997

In Brief: Lippman Leads M.D. Anderson Clinical Prevention; Baylin Named Ludwig Professor

May 10, 1996

Complete List of Recommendations by Centers Committee

October 18, 1996

Hepatitis B Vaccine Almost Ready, Blumberg Tells Science Writers

April 10, 1981

In Brief: Three Patients Evaluated For Gene Therapy; Revised Program Instructions Available

November 30, 1990